Crossmark

Resveratrol inhibits pancreatic cancer progression via the ING5 signaling pathway

Published Online: 2026-03-13

Authors

Wang, Guotai

Yuan, Yuan

Tang, Yi

Ma, Qingyong

Jiang, He https://orcid.org/0000-0001-8679-7476
Funding

Funding for this research was provided by:

Shaanxi Provincial Administration of Traditional Chinese Medicine TCM Research Project

Qinchuangyuan Traditional Chinese Medicine Industry Innovation Cluster Project

Xianyang Young and Middle-aged Scientific and Technological Leading Talent Project
License Information

Text and Data Mining valid from 2026-03-13

Accepted Manuscript valid from 2026-03-13
More Information

Article History

Received: 26 October 2025

Accepted: 10 March 2026

First Online: 13 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current